Sir Bruce Keogh said the review into cosmetic surgery should be complete by the end of the year. Keogh told BBC Breakfast the review will address the "cacophony of concern" about "grubby practice" that was inflicting some parts of the industry.
This whole debate has raised a cacophony of concern across society. There are people who are concerned about the regulation, there are people who are very concerned about the qualifications of those who are conducting, in the dark recesses of the cosmetic industry, procedures that they are not qualified to do.
There are, sadly though, some parts where there are some pretty grubby practices going on and that's why we're having the review.
A major review into cosmetic surgery is being launched in light of the PIP scandal. Daybreak speaks to inquiry author Sir Bruce Keogh.
A major review into cosmetic surgery is being launched in light of the PIP scandal. Daybreak's Tiffany Royce reports.
NHS medical director Sir Bruce Keogh has promised to clean up the "grubby areas" of an industry that he says does not give patients enough protection, according to The Times.
He said that though there were some very good clinics his inquiry would raise hard questions for the whole industry.
He told the newspaper: "You can be a commercial operation that's well run but are you an ethical operation? Is your practice... driven purely by financial considerations?"
- Nearly 750 women have PiP implants removed on NHS - 490 of whom had their PIP implants put in at private clinics.
- 4,349 scans have been done.
- 490 women have decided to have their implants removed on the NHS.
The NHS Medical Directors expert group said in June that the gel materials used inside the implants are not toxic or carcinogenic.
However it warned that PIP implants are twice as likely to rupture as other brands.
The group, led by NHS medical director Professor Sir Bruce Keogh, found that after 10 years the PIP implants have a 15% to 30% chance of rupturing.
Other breast implant brands have a 10% to 14% rupture rate in the same timeframe.
The implants also contain the chemical compound siloxane which is chemically similar to silicone and is found in many consumer products including hair and skin products and antiperspirants and deodorants.
But the experts said the chemical does not present a health risk.
NHS medical director Sir Bruce Keogh, who will lead the inquiry into cosmetic surgery, will recommend tighter rules in several key areas;
- Making it routine practice for surgeons to register all devices - from breast implants to hip replacements - on a detailed register that could be used to detect trends and trace individual patients.
- Requiring clinics to join a scheme, similar to that run by the travel industry, that would offer patients protection if a company went bust.
- tightening the rules on anti-ageing dermal fillers, which require only basic safety checks and can legally be injected by anyone.
- Introducing minimum training requirements for surgeons carrying out cosmetic procedures.
An expert panel, including PIP campaigner Catherine Kydd, former medical director of Bupa Andrew Vallance-Owen and editor of Marie Claire magazine Trish Halpin, will gather evidence before making recommendations to the Government next March.
Members of the public are also being asked to share their experiences of cosmetic surgery and views on issues including the safety of products used in such procedures, care during and after treatment, and how much advice is given to those considering surgery.
The review comes as a ComRes survey of 1,762 people showed that only half take the qualifications of a practitioner into consideration - 54% for surgery and 50% for non-surgical procedures.
Two thirds of those questioned, 67% for surgery and 66% for non-surgical procedures, said cost is a factor for them when deciding whether to have surgery.